Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(23 sites)
United States
Biogenix Molecular LLC, Miami, Florida NovaCure Health, Miami, Florida Emory University Hospital, Atlanta, Georgia XCancer Omaha / Urology Cancer Center, Omaha, Nebraska Weill Cornell Medicine - New York - Presbyterian Hospital, New York, New York